Embecta (EMBC) Competitors

Embecta (NASDAQ:EMBC) and Envista (NYSE:NVST) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, community ranking, dividends, institutional ownership, analyst recommendations, earnings and valuation.

Do institutionals and insiders hold more shares of EMBC or NVST?

93.8% of Embecta shares are owned by institutional investors. 0.4% of Embecta shares are owned by company insiders. Comparatively, 1.3% of Envista shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Does the media refer more to EMBC or NVST?

In the previous week, Embecta had 4 more articles in the media than Envista. MarketBeat recorded 6 mentions for Embecta and 2 mentions for Envista. Embecta's average media sentiment score of 1.60 beat Envista's score of 0.87 indicating that Embecta is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Embecta	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Envista	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has stronger valuation & earnings, EMBC or NVST?

Embecta has higher earnings, but lower revenue than Envista. Envista is trading at a lower price-to-earnings ratio than Embecta, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Embecta	$1.11B	0.66	$78.30M	$1.00	12.65
Envista	$2.51B	1.20	-$1.12B	-$6.49	-2.69

Do analysts recommend EMBC or NVST?

Embecta currently has a consensus price target of $23.00, indicating a potential upside of 81.82%. Envista has a consensus price target of $20.18, indicating a potential upside of 15.70%. Given Embecta's stronger consensus rating and higher possible upside, equities research analysts clearly believe Embecta is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Embecta	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Envista	2 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.07

Which has more risk & volatility, EMBC or NVST?

Embecta has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500. Comparatively, Envista has a beta of 1.33, suggesting that its stock price is 33% more volatile than the S&P 500.

Is EMBC or NVST more profitable?

Embecta has a net margin of 5.25% compared to Envista's net margin of -44.56%. Envista's return on equity of 3.86% beat Embecta's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Embecta	5.25%	-19.22%	11.92%
Envista	-44.56%	3.86%	2.21%

Does the MarketBeat Community prefer EMBC or NVST?

Envista received 33 more outperform votes than Embecta when rated by MarketBeat users. Likewise, 33.33% of users gave Envista an outperform vote while only 6.25% of users gave Embecta an outperform vote.

Company	Underperform	Outperform
Embecta	Outperform Votes 1 6.25%	Underperform Votes 15 93.75%
Envista	Outperform Votes 34 33.33%	Underperform Votes 68 66.67%

Summary

Embecta beats Envista on 10 of the 18 factors compared between the two stocks.